TrialHepatology communications2025

Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial.

Yoshitaka Arase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.